[1] |
谢幸,苟文丽. 妇产科学.8版[M]. 北京:人民卫生出版社,2013: 64-71.
|
[2] |
刘静芳,刘国莉,王建六. 预测子痫前期发病相关因素的研究进展[J]. 现代妇产科进展,2013, 22(2): 159-162.
|
[3] |
林其德,段涛,孔北华,等. 子痫前期-子痫相关问题的讨论[J]. 现代妇产科进展,2006, 15(9): 641-653.
|
[4] |
Sun L, Liu Y, Lin S, et al. Early growth response gene-1 and hypoxia-inducible factor-1α affect tumor metastasis via regulation of tissue factor[J]. Acta Oncol, 2013, 52(4): 842-851.
|
[5] |
Herraiz I, Simón E, Gómez-Arriaga P, et al. Angiogenesis-related biomarkers (sFlt-1/PLGF) in the prediction and diagnosis of placental dysfunction: an approach for clinical integration[J]. Int J Mol Sci, 2015, 16(8): 19009-19026.
|
[6] |
Chang SD, Chao AS, Peng HH, et al. Analyses of placental gene expression in pregnancy-related hypertensive disorders[J]. Taiwan J Obstet Gynecol, 2011, 50(3): 283-291.
|
[7] |
Zezza L, Ralli E, Conti E, et al. Hypertension in pregnancy: the most recent findings in pathophysiology, diagnosis and therapy[J]. Minerva Ginecol, 2014, 66(1): 103-126.
|
[8] |
Hawfield A, Freedman BI. Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection[J]. Ther Adv Cardiovasc Dis, 2009, 3(1): 65-73.
|
[9] |
Naicker T, Dorsamy E, Ramsuran D, et al. The role of apoptosis on trophoblast cell invasion in the placental bed of normotensive and preeclamptic pregnancies[J]. Hypertens Pregnancy, 2013, 32(3): 245-256.
|
[10] |
彭文,王燕芸,贾颐舫. 子痫前期患者胎盘组织及外周血PLGF和sFlt-1的表达及作用机制[J]. 中国妇幼保健,2015, 30(26): 4559-4561.
|
[11] |
Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation[J]. Mol Cell Biol, 1992, 12(12): 5447-5454.
|
[12] |
Yamamoto Y, Ibusuki M, Okumura Y, et al. Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer[J]. Breast Cancer Res Treat, 2008, 110(3): 465-475.
|
[13] |
Wang GP, Zhang H, Zhang ZF, et al. Clinical and pathological characteristics of intraductal proliferative lesions and coexist with invasive ductal carcinomas[J]. Chinese-German J Clin Oncol, 2013, 12(12): 574-580.
|
[14] |
Palmer KR, Kaitu′u-Lino TJ, Hastie R, et al. Placental-specific sFLT-1 e15a protein is increased in preeclampsia, antagonizes vascular endothelial growth factor signaling, and has antiangiogenic activity[J]. Hypertension, 2015, 66(6): 1251-1259.
|
[15] |
Tsatsaris V, Goffin F, Munaut C, et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences[J]. J Clin Endocrinol Metab, 2003, 88(11): 5555-5563.
|
[16] |
Henao DE, Cadavid AP, Saleem MA. Exogenous vascular endothelial growth factor supplementation can restore the podocyte barrier-forming capacity disrupted by sera of preeclamptic women[J]. J Obstet Gynaecol Res, 2013, 39(1): 46-52.
|
[17] |
Chedraui P, Lockwood CJ, Schatz F, et al. Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia[J]. J Matern Fetal Neonatal Med, 2009, 22(7): 565-570.
|
[18] |
Ahamad S, Hewett PW, Al-Ani B, et al. Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis[J]. Vasc Cell, 2011, 3(1): 15.
|
[19] |
Sezer SD, Küçük M, Döger FK, et al. VEGF, PIGF and HIF-1α in placentas of early- and late-onset pre-eclamptic patients[J]. Gynecol Endocrinol, 2013, 29(8): 797-800.
|
[20] |
Akhilesh M, Mahalingam V, Nalliah S, et al. Hypoxia-inducible factor-1α as a predictive marker in pre-eclampsia[J]. Biomed Rep, 2013, 1(2): 257-258.
|
[21] |
鲁晓燕,刘曼华,赵枰,等. 孕妇血清缺氧诱导因子1α水平与子痫前期病理特点的关系[J]. 山东医药,2013, 53(38): 64-65.
|
[22] |
Giguère Y, Charland M, Bujold E, et al. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review[J]. Ann Biol Clin (Paris), 2011, 69(3): 257-271.
|
[23] |
冯敏,杨海澜,王海燕,等. 血清及尿液中sFlt-1/PLGF比值的变化与子痫前期相关性研究[J]. 中国妇幼保健,2011, 26(6): 829-831.
|
[24] |
陶娅玲,漆洪波. 子痫前期孕妇血清及尿液中VEGF、PLGF、sFlt-1水平变化及意义[J]. 实用妇产科杂志,2008, 24(8): 496-498.
|
[25] |
Rana S, Karumanchi SA, Levine RJ, et al. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia[J]. Hypertension, 2007, 50(1): 137-142.
|
[26] |
Baltajian K, Hecht JL, Wenger JB, et al. Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia[J]. Hypertens Pregnancy, 2014, 33(4): 427-439.
|